002437 誉衡药业
2025/03 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资68,144-0.22%68,29368,544282,144294,663
投资性房地产34,178-0.95%34,50532,47433,6660
固定资产1,011,788-1.17%1,023,7431,055,5691,106,5441,233,477
在建工程1,821-3.40%1,8853,04512,8901,796
无形资产189,13713.49%166,662191,300221,182290,341
商誉369,0320.00%369,032369,032369,032411,160
其他非流动资产257,960-9.10%283,799278,036232,530263,281
1,932,060-0.81%1,947,9181,998,0002,257,9882,494,719

流动资产
货币资金461,762-4.19%481,963711,2751,237,7431,495,713
应收账款106,995-14.32%124,884205,240228,592225,055
存货185,856-1.49%188,672190,667214,136352,092
其他流动资产191,979135.05%81,67747,268135,726127,565
946,5917.91%877,1941,154,4501,816,1982,200,424

流动负债
短期借款70,042--0675,6901,454,9731,558,129
应付票据0--000100,000
应付帐款64,3086.39%60,44669,87675,481170,487
其他流动负债757,562-0.66%762,587665,584805,856849,713
891,9118.37%823,0341,411,1502,336,3102,678,329
流动资产净值54,6800.96%54,161(256,701)(520,112)(477,905)
资产总额减流动负债1,986,740-0.77%2,002,0791,741,3001,737,8762,016,815

非流动负债
长期借款0--0000
应付债券0--0000
其他非流动负债28,446-2.67%29,22731,06934,33537,901
28,446-2.67%29,22731,06934,33537,901

总权益
    实收股本2,247,443-1.42%2,279,7502,198,1232,198,1232,198,123
    储备项目(312,983)-4.88%(329,053)(536,350)(566,885)(303,910)
股东权益1,934,459-0.83%1,950,6971,661,7731,631,2381,894,213
非控股权益23,8347.58%22,15548,45772,30484,700